303 related articles for article (PubMed ID: 2286317)
21. Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.
Fagerberg J; Hjelm AL; Ragnhammar P; Frödin JE; Wigzell H; Mellstedt H
Cancer Res; 1995 May; 55(9):1824-7. PubMed ID: 7728746
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the idiotypic network in tumor immunity.
Raychaudhuri S; Saeki Y; Chen JJ; Kohler H
J Immunol; 1987 Dec; 139(11):3902-10. PubMed ID: 2824616
[TBL] [Abstract][Full Text] [Related]
23. A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody.
Sutjita M; Hohmann A; Comacchio R; Boey ML; Bradley J
Clin Exp Immunol; 1989 Feb; 75(2):211-6. PubMed ID: 2784733
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal anti-idiotype antibody 6G6.C4 fused to GM-CSF is capable of breaking tolerance to carcinoembryonic antigen (CEA) in CEA-transgenic mice.
Schwegler C; Dorn-Beineke A; Nittka S; Stocking C; Neumaier M
Cancer Res; 2005 Mar; 65(5):1925-33. PubMed ID: 15753392
[TBL] [Abstract][Full Text] [Related]
25. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
[TBL] [Abstract][Full Text] [Related]
26. [Antigen mimicry of anti-idiotypic antibodies for human ovarian carcinoma antigen: generation and characterization of anti anti-idiotype antibodies].
Lu WY; Qian HN
Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):581-3, 636. PubMed ID: 7508814
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of a murine B cell tumor with antibodies and F(ab')2 fragments against idiotypic determinants of its cell surface IgM.
Perek Y; Hurwitz E; Burowski D; Haimovich J
J Immunol; 1983 Sep; 131(3):1600-3. PubMed ID: 6604103
[TBL] [Abstract][Full Text] [Related]
28. Radiolabeled monoclonal antibody being studied as "vaccine" in ovarian cancer patients.
Oncology (Williston Park); 1993 May; 7(5):57. PubMed ID: 8512783
[No Abstract] [Full Text] [Related]
29. [Clinical application of anti-idiotypic antibody].
Yachi A; Tsujisaki M; Imai K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2313-20. PubMed ID: 2665652
[TBL] [Abstract][Full Text] [Related]
30. Development of anti-idiotype monoclonal antibodies for Sialyl Le(a) antigen.
Furuya A; Yoshida H; Hanai N
Anticancer Res; 1992; 12(1):27-31. PubMed ID: 1567176
[TBL] [Abstract][Full Text] [Related]
31. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
Reinsberg J; Krebs D
Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of immunological responses in patients with ovarian cancer treated with the anti-idiotype vaccine ACA125 by determination of intracellular cytokines--a preliminary report.
Reinartz S; Boerner H; Koehler S; Von Ruecker A; Schlebusch H; Wagner U
Hybridoma; 1999 Feb; 18(1):41-5. PubMed ID: 10211787
[TBL] [Abstract][Full Text] [Related]
33. Monitoring cancer antigen 125 in serum of ovarian cancer patients after administration of 131I-labeled F(ab')2 fragments of OC125 antibody.
Reinsberg J; Schultes B; Wagner U; Krebs D
Clin Chem; 1993 May; 39(5):891-6. PubMed ID: 8485883
[TBL] [Abstract][Full Text] [Related]
34. Falsely low results in CA 125 determination due to anti-idiotypic antibodies induced by infusion of [131I]F(ab')2 fragments of the OC125 antibody.
Reinsberg J; Nocke W
Eur J Clin Chem Clin Biochem; 1993 May; 31(5):323-7. PubMed ID: 8357942
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies and idiotypic network activation for ovarian carcinoma.
Wagner U; Reinsberg J; Schmidt S; Mallmann P; Schmolling J; Schultes B; Richter H; Biersack HJ; Krebs D
Cell Biophys; 1994; 24-25():237-42. PubMed ID: 7736528
[TBL] [Abstract][Full Text] [Related]
36. Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies.
Courtenay-Luck NS; Epenetos AA; Sivolapenko GB; Larche M; Barkans JR; Ritter MA
Lancet; 1988 Oct; 2(8616):894-7. PubMed ID: 2902328
[TBL] [Abstract][Full Text] [Related]
37. Idiotypic cascades after injection of the monoclonal antibody OC125. A study in a mouse model.
Schultes BC; Reinsberg J; Wagner U; Schlebusch H; Richter H; Krebs D; Biersack HJ
Cell Biophys; 1994; 24-25():259-66. PubMed ID: 7736531
[TBL] [Abstract][Full Text] [Related]
38. Antitumor antibodies for immunotherapy of ovarian carcinomas.
Wagner U
Hybridoma; 1993 Oct; 12(5):521-8. PubMed ID: 8300125
[No Abstract] [Full Text] [Related]
39. Confirmation of a false-positive result in CA 125 immunoradiometric assay caused by human anti-idiotypic immunoglobulin.
Klug TL; Green PJ; Zurawski VR; Davis HM
Clin Chem; 1988 Jun; 34(6):1071-6. PubMed ID: 2454168
[TBL] [Abstract][Full Text] [Related]
40. Titration calorimetry study of an anti-idiotypic antibody cascade in a human melanoma-associated antigen system.
Mutz M; Hawthorne T; Ferrone S; Pluschke G
Mol Immunol; 1997 Jul; 34(10):695-707. PubMed ID: 9430197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
